Press release
Lixisenatide Market Booming Worldwide with Latest Trend and Future Scope by 2029
Lixisenatide market is anticipated to grow at a significant CAGR during the forecast period. Lixisenatide is a once-daily injectable GLP-1 receptor agonist. It is sold under the brand name Lyxumia in the European Union and Adlyxin in the US. It is manufactured by Sanofi and is used to treat type 2 diabetes. The major factor driving the demand for lixisenatide is the increasing prevalence of diabetes across the globe.According to the International Diabetes Federation (IDF), in 2021, approximately 537 million adults aged 20-79 years has diabetes globally with 3 in 4 adults with diabetes living in low- and middle-income countries with a mortality rate of 6.7 million people globally. Additionally, the total number of people living with diabetes is anticipated to rise to 643 million by 2030 and 783 million by 2045. Moreover, almost 1 in 2 (240 million) adults living with diabetes are undiagnosed. Hence, the rising prevalence of diabetes is encouraging the demand for lixisenatide.
Some major players in the market include Zealand Pharma A/S and Sanofi SA, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in October 2019, Sanofi announced the launch of Suliqua (insulin glargine/lixisenatide) in the UK. The drug is a once-daily, titratable, fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide used to treat type 2 diabetes in adults.
To Request a Sample of our Report on Lixisenatide Market: https://www.omrglobal.com/request-sample/lixisenatide-market
Market Coverage
The market number available for - 2022-2030
Base year- 2022
Forecast period- 2023-2030
Segment Covered-
By Product
By Type of Manufacturing
By End-User
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Zealand Pharma A/S, and Sanofi SA, among others.
Lixisenatide Market Report by Segment
By Product
Industrial Grade
Pharmaceutical Grade
By Type of Manufacturing
In-house Manufacturing
Contract Manufacturing Organizations
A full Report of Lixisenatide Market is Available @ https://www.omrglobal.com/industry-reports/lixisenatide-market
Lixisenatide Market Report by Region
North America
United States
Canada
Europe
UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific
India
China
Japan
South Korea
Rest of APAC
Rest of the World
Latin America
Middle East & Africa
Reasons to buy from us -
We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.
https://www.somosxbox.com.mx/noticias-urgente/tasa-de-crecimiento-lento-del-mercado-de-vacunas-de-vectores-recombinantes-prevista-para-2023-2030/119327/
https://perualdia.net/el-mercado-de-gestion-de-trafico-sera-testigo-de-la-aceleracion-del-crecimiento-para-2028/
https://ekz-crosstour.ch/news/nordamerikanische-marktanalyse-fuer-elektrogehaeuse-groesse-aktuelles-szenario-und-zukunftsaussichten/122952/
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lixisenatide Market Booming Worldwide with Latest Trend and Future Scope by 2029 here
News-ID: 3213860 • Views: …
More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…

Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…

Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…

Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for Lixisenatide
Lixisenatide Injection Market Outlook and Future Projections for 2030
The lixisenatide injection market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Lixisenatide Market Industry Share, Size: 2024 with Growth, Segments and Forecas …
The global lixisenatide market is anticipated to grow at a considerable CAGR during the forecast period (2024-2031). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in June 2021, Novo Nordisk received US Food and Drug Administration (FDA) approval of Wegovy (semaglutide)…
Lixisenatide Market to Witness Growth Acceleration by 2029
Lixisenatide market is anticipated to grow at a significant CAGR during the forecast period. Lixisenatide is a once-daily injectable GLP-1 receptor agonist. It is sold under the brand name Lyxumia in the European Union and Adlyxin in the US. It is manufactured by Sanofi and is used to treat type 2 diabetes. The major factor driving the demand for lixisenatide is the increasing prevalence of diabetes across the globe.
According to…
Lixisenatide Market | Top Players, Types, Applications, Regional Analysis 2019-2 …
The study report on the Lixisenatide Market has assessed the historical and current performance of this market, especially highlighting the key trends and growth opportunities. It also gives the SWOT analysis and global revenue and sales 2018-2023.
According to the latest research, the rising demand for this product is driving the Lixisenatide Market significantly. The expansion in the various related industry is also expected to reflect positively on the sales of…
Global Lixisenatide Market Opportunities and Industry Analysis Report to 2024
Market Research Mentor Data has launched a research report on the Global Lixisenatide Market that predicts future market trends and current market trends. It includes analytic data of the lixisenatide Market about growth rate, size, market trends, profitability, manufacturers, applications, historical data, popular regions, etc. The valuable detailed research report created by skilled industry experts, who are experienced in this research industry. This report on the Global lixisenatide Market will…
2018 Lixisenatide Market Development Trends, Competitive Landscape and Key Regio …
ReportsnReports recently announces a latest research report titled “Global Lixisenatide Market 2018” which highlights the Lixisenatide Market size, comprehensive Lixisenatide Industry dynamics and high-tech updates of global Lixisenatide Market with respect to Lixisenatide Industry opportunities, threats, challenges, constraints, cost structure and current trends in the Lixisenatide Industry. This independent 108 Page report based on analysis over 2 Major Key Players guarantees you will remain better informed than your competition. Lixisenatide…